What is Circuit Clinical?
Circuit Clinical operates at the intersection of patient care and clinical trial efficiency. By functioning as an IRO, the company empowers patients to view clinical research as a viable care option, effectively transforming the traditional trial participation experience. Central to its value proposition is TrialScout, a proprietary ratings and reviews platform that provides transparency and insights into the trial process. This technology-driven approach not only accelerates patient enrollment but also ensures higher retention rates through study completion. By supporting physicians with expert in-office research teams, Circuit Clinical addresses the critical bottlenecks in drug development, positioning itself as a vital partner for pharmaceutical and biotechnology firms seeking to optimize their clinical trial pipelines.
How much funding has Circuit Clinical raised?
Circuit Clinical has raised a total of $29M across 1 funding round:
Unspecified
$29M
Unspecified (2022): $29M with participation from Labcorp, Rochester Angel Network, Medidata, Western New York Impact Investment Fund, and Launch NY
Key Investors in Circuit Clinical
Labcorp
Labcorp is a global leader in laboratory services, providing comprehensive diagnostic and biopharma laboratory solutions to support medical research and patient care.
Rochester Angel Network
The Rochester Angel Network is a prominent group of accredited investors focused on early-stage, high-growth investment opportunities in Upstate New York.
Launch NY
Launch NY is a venture development organization dedicated to identifying and supporting high-growth companies to drive economic development in Western New York.
What's next for Circuit Clinical?
With this major enterprise-level funding, Circuit Clinical is well-positioned to accelerate its growth trajectory and solidify its market leadership. The strategic focus will likely center on scaling the TrialScout platform to reach a broader demographic of patients and healthcare providers, thereby increasing the velocity of clinical trial recruitment. Furthermore, the company is expected to deepen its integration with existing research networks, enhancing the quality of data collection and patient outcomes. As the clinical research industry continues to prioritize patient-centricity, Circuit Clinical's ability to combine human expertise with digital tools provides a sustainable competitive advantage. Future initiatives will likely involve expanding into new therapeutic areas and strengthening partnerships with major industry stakeholders to drive long-term value creation.
See full Circuit Clinical company page
